{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/43005528"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "DMCs were initially used primarily in large randomized multicenter trials sponsored by federal agencies, such as the National Institutes of Health (NIH) and the Department of Veterans Affairs (VA) in the U.S. and similar bodies abroad, that targeted improved survival or reduced risk of major morbidity (e.g., acute myocardial infarction) as the primary objective." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "fda.gov" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/254823902"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/43005528"] } } }
